bc007

Safety, tolerability and clinical effects of BC007 on fatigue and quality of life in patients with post-COVID syndrome (reCOVer): a prospective, exploratory, randomised , placebo-controlled, double-blind, crossover phase IIa clinical trial Bettina Hohberger, Marion Ganslmayer, Thomas Harrer...

Change.org petition to fund and expedite BC-007 research BC007 NOW- Chance of a cure for millions of suffering people From the English description call on the German government to financially support the approval studies of the company Berlin Cures GmbH for the drug BC 007 and to remove...

With EMEC we are trying to set up a meeting with representatives of The European Federation of Pharmaceutical Industries and Associations (EFPIA). We are compiling a list of drugs that seem most promising for the treatment of ME/CFS and the pharmaceutical companies that make them. An example...

WE NEED 800 000 € for a medical study at the University Hospital Erlangen with the drug BC007 of the company "Berlin Cures" for ME/CFS patients https://wir-fordern-forschung.org/en/ "What is BC007? - Why this drug? The University Hospital Erlangen made a significant discovery in July 2021: A...

Full title: Neutralization of Autoantibodies Targeting G-Protein Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms after COVID-19 Infection Abstract Clinical features of Corona Virus Disease 2019 (COVID-19) are caused by the severe acute respiratory syndrome coronavirus-2...

Autoantibody helps with Long Covid The German article https://www.fau.de/2021/07/news/medikament-gegen-autoantikoerper-hilft-bei-long-covid/ The paper is most interesting because of microcirculation, plus the use of BC 007, originally a heart related drug, as a treatment...

Abstract Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones reported but are not caused by...